Expansion in Hungary: SCHOTT and Hungarian government invest in cutting-edge syringe production
Thursday, March 10, 2022, LUKÁCSHÁZA, HUNGARY / MAINZ, GERMANY
- The 76 million Euro (28,044 billion HUF) investment in Hungary is designed to meet the growing global demand for prefillable syringes made of glass.
- The brand new production is planned at SCHOTT’s existing site in Lukácsháza.
Already today, SCHOTT’s Hungarian site in Lukácsháza plays an important role in supplying the global industry with drug containment systems and provides enough space for further capacity expansions to follow.
Building on the strong existing foundation and skillset, the production will be equipped with state-of-the-art machinery. As part of SCHOTT’s global production network in 13 countries, the manufacturing will follow high-end processes and advanced quality assurance.
More information on syriQ® prefillable glass syringes
syriQ® is a registered trademark of SCHOTT AG.